MA
XBIT icon

MUFG Americas’s XBiotech XBIT Stock Holding History

MUFG Americas’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-520
Closed -$6K – 1246
2015
Q4 		$6K Buy
+520
New +$6.64K ﹤0.01% 914

Other funds holding XBIT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

MUFG Americas's XBIT Position: Q1 2016 in Review

MUFG Americas sold out of XBiotech (XBIT) in Q1 2016, closing a stake of 520 shares — an estimated $6K sold.

MUFG Americas first reported a position in XBIT in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 32 funds tracked by Wall St. Rank hold XBIT as of Q1 2016.

  • MUFG Americas reported no remaining XBiotech position as of Q1 2016 after selling out during the quarter.
  • MUFG Americas sold 520 XBiotech shares in Q1 2016, an estimated $6K.
  • MUFG Americas first reported a position in XBiotech in Q4 2015 and held it in 1 quarter.
  • MUFG Americas's XBiotech position peaked at $6K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held XBiotech as of Q1 2016.

Based on MUFG Americas's 13F filing for Q1 2016, filed 11 May 2016.